Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.62 - $12.37 $4.06 Million - $8.94 Million
-723,055 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$10.65 - $18.61 $817,983 - $1.43 Million
-76,806 Reduced 9.6%
723,055 $8.84 Million
Q3 2021

Nov 15, 2021

BUY
$14.65 - $26.07 $5.86 Million - $10.4 Million
399,861 Added 99.97%
799,861 $13.2 Million
Q2 2021

Aug 16, 2021

BUY
$28.0 - $28.0 $11.2 Million - $11.2 Million
400,000 New
400,000 $11.2 Million

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $363M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.